Xenerex Biosciences - 92121 San Diego, CA

Business Name: Xenerex Biosciences
Categorized In: Medical Research
Address: 11388 Sorrento Valley Road, San Diego, CA 92121
Phone Number: (319) 266-5542
Contact Person: Eric Brandt
Website Address: avanir.com
NAICS Code: 541720
SIC Code: 8733
Business Type: B2B (Business to Business)
Founding Year: 2000
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): Unknown
Share This Business:
Similar Businesses: Arcturus Therapeutics Inc - San Diego, CA 92121
Gl Pharmaceuticals, Inc - San Diego, CA 92121
Kanda Med Biotech Center Inc - San Diego, CA 92121
Medinox Inc - San Diego, CA 92121
Muscular Dystrophy Assn - San Diego, CA 92121
The Whittier Institute For Diabetes - San Diego, CA 92121
Medecell - San Diego, CA 92121
Tissue Repair Company - San Diego, CA 92121
Halder Biologics - San Diego, CA 92121
Torrey Pines Institute - San Diego, CA 92121
Fqubed Inc - San Diego, CA 92121
Amulaire Thermal Technologies - San Diego, CA 92121
Axikin Pharmaceuticals Inc - San Diego, CA 92121
Cythera Inc - San Diego, CA 92121
Brain Cells Inc - San Diego, CA 92121
Idun Pharmaceuticals Inc - San Diego, CA 92121
Victorch Meditek Inc - San Diego, CA 92121
La Jolla Bioengineering Institute - San Diego, CA 92121
Muscular Dystrophy Association Inc - San Diego, CA 92121
Zacharaon Pharmaceuticals Inc - San Diego, CA 92121

Xenerex Biosciences provides professional Medical Research from its single location at the coordinates .

The company offers B2B variables under the SIC code 8733 and NAICS code 541720, while making an annual revenue of Unknown and hiring a total of 1 to 4 employees.

Founded in 2000, the company can now be visited at 11388 Sorrento Valley Road, San Diego, California 92121 or contacted through representative Eric Brandt at (319) 266-5542.

For frequently asked questions and further inquiries about professional Medical Research, get to know more about Xenerex Biosciences through its company website at avanir.com. Engage with this business on its social media platforms through on Twitter and on Facebook.